School of Pharmacy, Universitas Muhammadiyah Yogyakarta, Yogyakarta, Indonesia.
Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
J Med Life. 2022 May;15(5):625-630. doi: 10.25122/jml-2021-0367.
Patient education is one of the important aspects of improving knowledge and quality of asthma control. In this digital era, it can be made with the support of an app - or known as mHealth. Unfortunately, implementing applications for patient education is relatively new among asthmatic patients in Indonesia. This study aimed to determine the efficacy of the educational content of the AsmaDroid® app on the levels of asthma knowledge among asthmatic patients. This study was a randomized controlled trial carried out from December 2019 to March 2020 in the Special Region of Yogyakarta, Indonesia. A quota sampling was employed, resulting in 140 study participants being categorized into control and treatment groups. Before and after the 4-week treatment period, all participants were asked to complete a pre-test and post-test of the Asthma General Knowledge Questionnaire for Adults (AGKQA) questionnaire. All the scores were then compared to determine the efficacy of educational content on the levels of asthma knowledge. The results of descriptive statistics reported that the pretest scores of AGKQA from the control group (minimum, maximum, and mean) were 9, 25, and 19.04±2.56, respectively, and post-test scores were 10, 27, and 18.79±3.59 (p=0.47). Meanwhile, in the treatment group, these were 13, 25, and 19.11±2.87, while post-test scores were 16, 31, 23.6±3.95 (p=0.01). Additionally, there was a difference between the post-test scores of the control and treatment groups, namely 4.81 (p=0.01). The educational content of the app significantly improved the levels of asthma knowledge.
患者教育是提高哮喘控制知识和质量的重要方面之一。在数字时代,可以在应用程序的支持下进行,也称为移动医疗。不幸的是,在印度尼西亚的哮喘患者中,应用程序的患者教育实施相对较新。本研究旨在确定 AsmaDroid®应用程序的教育内容对哮喘患者哮喘知识水平的疗效。这是一项 2019 年 12 月至 2020 年 3 月在印度尼西亚日惹特区进行的随机对照试验。采用定额抽样,将 140 名研究参与者分为对照组和治疗组。在 4 周治疗期前后,所有参与者都被要求完成成人哮喘知识总问卷(AGKQA)的预测试和后测试。然后将所有分数进行比较,以确定教育内容对哮喘知识水平的疗效。描述性统计报告结果显示,对照组的 AGKQA 预测试分数(最小值、最大值和平均值)分别为 9、25 和 19.04±2.56,后测试分数为 10、27 和 18.79±3.59(p=0.47)。而在治疗组中,这些分别为 13、25 和 19.11±2.87,后测试分数为 16、31、23.6±3.95(p=0.01)。此外,对照组和治疗组的后测试分数存在差异,即 4.81(p=0.01)。该应用程序的教育内容显著提高了哮喘知识水平。
Comput Methods Programs Biomed. 2021-11
Cochrane Database Syst Rev. 2013-11-27
J Med Internet Res. 2025-3-18
NPJ Prim Care Respir Med. 2023-10-14
Comput Methods Programs Biomed. 2021-11
J Allergy Clin Immunol Pract. 2020-6
J Allergy Clin Immunol. 2019-7-19
J Allergy Clin Immunol Pract. 2019-4-4
Elife. 2019-2-20
Int J Environ Res Public Health. 2018-10-29
J Patient Exp. 2017-3
J Allergy Clin Immunol Pract. 2017
J Allergy Clin Immunol Pract. 2016-6-8
Ther Adv Chronic Dis. 2016-1